Determination of ketoconazole in human plasma by high-performance liquid chromatography - tandem mass spectrometry

被引:29
作者
Chen, YL [1 ]
Felder, L [1 ]
Jiang, XY [1 ]
Naidong, W [1 ]
机构
[1] Covance Labs Inc, Dept Bioanalyt Chem, Madison, WI 53704 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 774卷 / 01期
关键词
ketoconazole;
D O I
10.1016/S1570-0232(02)00209-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid and specific high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) has been developed and validated for the determination of ketoconazole in human plasma. The method used diethyl ether to extract the ketoconazole and the internal standard (I.S.) R51012 from alkalinized plasma sample. The LC separation was on a C-18 column (50x3 mm, 5 mum) using acetonitrile-water-formic acid (75:25:1, v/v/v) mobile phase. The retention times were approximately 1.8 min for both ketoconazole and the I.S. The MS-MS detection was by monitoring 531.2-->82.1 (m/z) for ketoconazole, and 733.5-->460.2 (m/z) for the I.S. The dynamic range was from 20.0 to 10 000 ng/ml based on 0.1 ml plasma, with linear correlation coefficient of greater than or equal to0.9985. The run time was 2.5 min/injection. The recoveries of ketoconazole and the I.S. were 102 and 106%, respectively. The precision and accuracy of the control samples were with the relative standard deviations (RSDs) of less than or equal to4.4% (n=6) and the relative errors (REs) from -0.6 to 1.4% for intra-day assay, and less than or equal to8.6% RSD (n = 18) and -1.4 to 0.9% RE for inter-day assay. The partial volume tests demonstrated good dilution integrity. Three freeze-thaw cycles, keeping plasma samples at ambient for 24 h, storing extracted samples at ambient for 24 h, and storing frozen plasma samples at approximately -20degreesC for up to 2 months did not show substantial effects. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 25 条
[1]   DETERMINATION OF THE ANTIFUNGAL AGENT, KETOCONAZOLE, IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ALTON, KB .
JOURNAL OF CHROMATOGRAPHY, 1980, 221 (02) :337-344
[2]   LIQUID-CHROMATOGRAPHIC ASSAY OF KETOCONAZOLE [J].
ANDREWS, FA ;
PETERSON, LR ;
BEGGS, WH ;
CRANKSHAW, D ;
SAROSI, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (01) :110-113
[3]   MICRO-DETERMINATION OF KETOCONAZOLE IN PLASMA OR SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BADCOCK, NR .
JOURNAL OF CHROMATOGRAPHY, 1984, 306 (MAR) :436-440
[4]   SIMPLIFIED BIOASSAY METHOD FOR MEASUREMENT OF FLUCYTOSINE OR KETOCONAZOLE [J].
BODET, CA ;
JORGENSEN, JH ;
DRUTZ, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :157-160
[5]   KETOCONAZOLE, AN ORAL ANTIFUNGAL - LABORATORY AND CLINICAL-ASSESSMENT OF IMIDAZOLE DRUGS [J].
BORELLI, D ;
FUENTES, J ;
LEIDERMAN, E ;
RESTREPO, A ;
BRAN, JL ;
LEGENDRE, R ;
LEVINE, HB ;
STEVENS, DA .
POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (647) :657-661
[6]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[7]  
CLAYTON YN, 1981, CLIN RES REV, V1, P189
[8]   DISEASES AND DRUGS BUT NOT FOOD DECREASE KETOCONAZOLE BIOAVAILABILITY [J].
DANESHMEND, TK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (06) :783-784
[9]   CLINICAL PHARMACOKINETICS OF KETOCONAZOLE [J].
DANESHMEND, TK ;
WARNOCK, DW .
CLINICAL PHARMACOKINETICS, 1988, 14 (01) :13-34
[10]   PHARMACOKINETICS OF KETOCONAZOLE IN NORMAL SUBJECTS [J].
DANESHMEND, TK ;
WARNOCK, DW ;
TURNER, A ;
ROBERTS, CJC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (04) :299-304